Medical Policy Updates

Notification of Policy Revisions Effective September 22, 2020 Posted July 21, 2020

Medical Policy Revision
Hematopoietic Cell Transplantation for Hodgkin Lymphoma "Notification" Updated Description and Policy Guidelines sections. Under When Not Covered section: coverage for tandem autologous HCT changed to investigational from medically necessary. Medical Director review 7/2020. Reference added. Notification 7/21/2020 for effective date 9/22/2020.